SecBot SecBot
SC 13G/A ·Filed Oct 28, 2026

MREO

Mereo BioPharma Group plc
NEUTRAL
Impact 2/10
Horizonweeks Processed1d 4h ago SEC0000070858-26-000531
Passive stake amendment
Actionable Insight • Neutral

Monitor for any future conversion to Schedule 13D if the investor's intent changes, but this filing confirms continued passive status. The stake reduction may reflect routine portfolio rebalancing.

DirectionNeutral
Confidencehigh
Horizonweeks
Latest settled: T+1d
MREO ▲ +1.62% at T+1d
NEUTRAL call +1.62% · α vs SPY +2.00% · entry $0.2970 → $0.3018
Next anchor: T+5d in 6d
Entry = T+0 close
Oct 28, 2026
via day close
T+1d
+1.62%
call +1.62% · α +2.00%
$0.3018
settled 10h ago
T+5d
Pending
in 6d
T+20d
Pending
in 27d
T+60d
Pending
in 3mo

Price Chart

Loading chart...

Executive Summary

Bank of America Corp filed an amended Schedule 13G disclosing a passive stake of 26,889,300 ordinary shares (3.4%) in Mereo BioPharma Group plc as of September 30, 2026. The stake decreased from the prior filing, and the filing is a routine passive ownership update with no material change in investment intent.

Key Financial Metrics

Stake
3.4%
Investor
BANK OF AMERICA CORP /DE/

Key Facts

  • Bank of America Corp reported beneficial ownership of 26,889,300 ordinary shares of Mereo BioPharma Group plc.
  • The stake represents 3.4% of the 798,454,864 outstanding shares as of August 10, 2026 (per issuer's Form 10-Q).
  • The filing is an amendment to Schedule 13G, indicating passive investment intent under Rule 13d-1(b).
  • The filing date is October 28, 2026, with a date of change of September 30, 2026.

Financial Impact

No financial impact; stake value not disclosed in filing.

Risk Factors

  • Potential further reduction in stake could signal waning institutional interest.
  • No material risk identified from this routine passive filing.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
77% bullish (13 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G/A Filing (Primary)0000070858-26-000531
Document: 0000070858-26-000531-index.html0000070858-26-000531
Document: 0000070858-26-000531.txt0000070858-26-000531
8 reports for MREO
Performance horizon
100% Hit rate @ T+5 3 of 3 directional calls Went positive at some point 3 of 3 best @ T+5▲ +10.75%Aug 19, 2026
Filters
Rows
Reports for MREO, sortable and filterable
TypeNow
Oct 28, 2026
1d ago
SC 13G/A
NEUTRAL ★ 2/10
$0.2970awaiting T+5awaiting T+5$0.3018 (+1.62%)
Aug 19, 2026
10w ago
8-K
BEARISH ★ 7/10
$0.3115 $0.2780▲ +10.75%▲ +10.37%$0.3018 (+3.11%)
Aug 11, 2026
11w ago
8-K
MIXED ★ 6/10
No priceawaiting T+5awaiting T+5No price
Aug 11, 2026
11w ago
Press Release
NEUTRAL ★ 4/10
$0.3060 $0.3130▲ +2.29%▲ +2.69%$0.3018 (−1.37%)
Aug 11, 2026
11w ago
8-K
BULLISH ★ 6/10
$0.3060 $0.3130▲ +2.29%▲ +2.69%$0.3018 (−1.37%)
Jun 11, 2026
20w ago
Institutional Cluster
NEUTRAL ★ 4/10
$0.3118 $0.3100▼ −0.58%▼ −1.01%$0.3018 (−3.21%)
May 12, 2026
24w ago
Press Release
BEARISH ★ 6/10
$0.2460 $0.2370▲ +3.66%▲ +3.74%$0.3018 (−22.68%)
Mar 19, 2026
32w ago
Press Release
MIXED ★ 6/10
$0.3610 $0.3390▼ −6.09%▼ −3.88%$0.3018 (−16.40%)
Showing 8 of 8

US Market Status

Market Closed · Opens Fri (15h 42m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 28, 2026